understood bio researcher...but 40x this year sales is fair isnt it? look almost every biotech that gets a drug approved..market starts to price differently...not only do they want to see explosive growth(hopefully we get that) but also want to see whats next and with ariad and 113 is still sometime away
im long the stock at a extremely low valuation..stock simply got way ahead of itself pre-approval(like most bios do)and market is simply bringing back to reality
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.